B. Dey

发表

Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein

J. Mascola, R. Wyatt, P. Kwong, 2008, Journal of Virology.

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Tongqing Zhou, Gary J. Nabel, Peter D. Kwong, 2007, Nature.

sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates

E. Berger, B. Dey, V. Villarroel, 2010, Retrovirology.

Vaccinia‐Based Reporter Gene Cell‐Fusion Assays to Quantitate Functional Interactions of HIV Envelope Glycoprotein with Receptors

E. Berger, B. Dey, 2003, Current protocols in immunology.

Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.

D. Vargas-Inchaustegui, E. Berger, B. Dey, 2018, Cytotherapy.

CDC 37 Is Required for p 60 vsrc Activity in Yeast

B. Dey, J. Lightbody, Frank Boschellit, 2022 .

Blocking HIV-1 gp120 at the Phe43 cavity: if the extension fits….

E. Berger, B. Dey, 2013, Structure.

Human Immunodeﬁciency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein (cid:1) †

J. Mascola, R. Wyatt, P. Kwong, 2008 .

Protein-based HIV-1 microbicides.

P. Lusso, B. Dey, L. Lagenaur, 2014, Current HIV research.

Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity

S. Rosenberg, R. Morgan, Zhili Zheng, 2015, Journal of Virology.

Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.

R. Wyatt, W. Hendrickson, P. Kwong, 2007, Journal of medicinal chemistry.

Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120

Q. Sattentau, M. Boyd, J. Lifson, 1999, Journal of Virology.

Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses

M. Boyd, D. L. Lerner, P. Lusso, 2000, Journal of Virology.

Characterization of Human Immunodeficiency Virus Type 1 Monomeric and Trimeric gp120 Glycoproteins Stabilized in the CD4-Bound State: Antigenicity, Biophysics, and Immunogenicity

Peter D. Kwong, John R. Mascola, Marie Pancera, 2007, Journal of Virology.

Neutralization of Human Immunodeficiency Virus Type 1 by sCD4-17b, a Single-Chain Chimeric Protein, Based on Sequential Interaction of gp120 with CD4 and Coreceptor

E. Berger, B. Dey, Christie S. Del Castillo, 2003, Journal of Virology.

Sequential CD4-Coreceptor Interactions in Human Immunodeficiency Virus Type 1 Env Function: Soluble CD4 Activates Env for Coreceptor-Dependent Fusion and Reveals Blocking Activities of Antibodies against Cryptic Conserved Epitopes on gp120

K. Salzwedel, E. Berger, B. Dey, 2000, Journal of Virology.

The Cerebellum‐Enriched Form of Nuclear Factor I Is Functionally Different from Ubiquitous Nuclear Factor I in Glial‐Specific Promoter Regulation

B. Dey, C. Krebs, G. Kumar, 1996, Journal of neurochemistry.

Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.

E. Go, H. Desaire, J. Mascola, 2018, Cell host & microbe.

Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site

Tongqing Zhou, Gary J. Nabel, Peter D. Kwong, 2009, PLoS pathogens.

B Cell Recognition of the Conserved HIV-1 Co-Receptor Binding Site Is Altered by Endogenous Primate CD4

J. Mascola, R. Wyatt, G. Shaw, 2008, PLoS pathogens.

Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection

E. Berger, B. Dey, 2015, Current opinion in HIV and AIDS.

Hyperglycosylated Stable Core Immunogens Designed To Present the CD4 Binding Site Are Preferentially Recognized by Broadly Neutralizing Antibodies

J. Mascola, R. Wyatt, W. Schief, 2014, Journal of Virology.